{"filing":{"accession_number":"0001104659-26-066345","cik":"0001130598","ticker":"TRAW","company_name":"Traws Pharma, Inc.","form":"8-K","filing_date":"2026-05-26","report_date":null,"primary_document":"tm2615554d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1130598/000110465926066345/tm2615554d1_8k.htm"},"events":[{"id":8981,"run_id":7884,"accession_number":"0001104659-26-066345","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"The filing discloses an At The Market (ATM) Offering Agreement entered into on March 10, 2025, permitting Traws Pharma to offer and sell up to $3,128,399 of common stock shares through Citizens JMP Securities under an effective shelf registration statement. ATM offerings are unregistered equity issuances that are dilutive to existing shareholders and typically signal capital-raising activity at small- and mid-cap issuers; this disclosure is material to investor assessment of equity dilution and the company's liquidity position.","company_name":"Traws Pharma, Inc.","ticker":"TRAW","filing_date":"2026-05-26","form":"8-K","submitted_at":null,"items":[{"id":1448,"accession_number":"0001104659-26-066345","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses an At The Market (ATM) Offering Agreement entered into on March 10, 2025, permitting Traws Pharma to offer and sell up to $3,128,399 of common stock shares through Citizens JMP Securities under an effective shelf registration statement. ATM offerings are unregistered equity issuances that are dilutive to existing shareholders and typically signal capital-raising activity at small- and mid-cap issuers; this disclosure is material to investor assessment of equity dilution and the company's liquidity position.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:08:38.331338+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1448,"accession_number":"0001104659-26-066345","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses an At The Market (ATM) Offering Agreement entered into on March 10, 2025, permitting Traws Pharma to offer and sell up to $3,128,399 of common stock shares through Citizens JMP Securities under an effective shelf registration statement. ATM offerings are unregistered equity issuances that are dilutive to existing shareholders and typically signal capital-raising activity at small- and mid-cap issuers; this disclosure is material to investor assessment of equity dilution and the company's liquidity position.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:08:38.331338+00:00","company_name":"Traws Pharma, Inc.","ticker":"TRAW","filing_date":"2026-05-26"}]}